Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
April 04, 2024 07:05 ET
|
Celcuity Inc.
MINNEAPOLIS, April 04, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that...
IMN celebrates 30th Anniversary as the Premier Real Estate Conference Organizer
March 27, 2024 09:00 ET
|
IMN
Hosting over 50 events annually, IMN provides a high-quality intelligence and networking platform that drives industry connections, deal flow and knowledge
HR Community Readies for Next Month’s EPIC Conference in Las Vegas
March 27, 2024 07:00 ET
|
EPIC
HR Community Readies for Next Month’s EPIC Conference in Las Vegas
Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
March 22, 2024 12:30 ET
|
Marker Therapeutics
HOUSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for...
HR Technology Conference & Exposition® Europe Announces Additional Agenda Details
March 18, 2024 06:00 ET
|
HR Technology Conference & Exposition (R)
HR Technology Conference & Exposition® Europe to Offer Unfettered Access to Industry’s Leading Thinkers
The Devon Group Expands Partner Program, Teams Up with Sara in the City Events
February 28, 2024 07:00 ET
|
The Devon Group
The Devon Group Expands Partner Program, Teams Up with Sara in the City Events
Mendus medverkar på flera branschkonferenser
February 27, 2024 02:00 ET
|
Mendus AB
Pressmeddelande Stockholm den 27 februari 2024 Mendus AB (“Mendus” publ; IMMU. ST), ett biofarmabolag med fokus på immunterapier riktade mot tumöråterfall, meddelade idag att bolaget kommer att...
Mendus to participate in upcoming industry conferences
February 27, 2024 02:00 ET
|
Mendus AB
Press release Stockholm, Sweden, February 27, 2024 Mendus AB ("Mendus" publ; IMMU. ST), a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, today announced that it...
Ocugen Chairman and CEO to present at Abu Dhabi Family Office Summit
February 26, 2024 08:30 ET
|
Ocugen
MALVERN, Pa., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene...
MC2 Therapeutics to Present at Upcoming Conferences
February 26, 2024 07:00 ET
|
MC2 Therapeutics
MC2 Therapeutics to Present at Upcoming Conferences Copenhagen, February 26th, 2024 – MC2 Therapeutics, a commercial stage biotech company focused on developing novel treatment paradigms within...